Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Nuclear Medicine and Molecular Imaging Technology is a patient-oriented program that combines chemistry, physics, mathematics, computer technology, and medicine using radioactivity to construct images of organs and study physiological processes for diagnostic, therapeutic and research purposes.
Nuclear medicine and molecular imaging are playing an increasingly important role in patient care, medical research, and pharmaceutical development, and the conventional pharmaceutical industry has gradually become interested in nuclear medicine, this mainly is considered as the key driver fueling the Nuclear Medicine Molecular Imaging Technology market, according to research, the global Nuclear Medicine Molecular Imaging Technology market is projected to grow at a CAGR of 5.7% during 2018-2022, reach 5.8 billion USD by 2022.
Geographically, North America and Europe is expected to capture the largest market shares due to it is expected to grow due to rapid technological innovations, large consumer base, and high disposable income. Followed by Asia Pacific countries, Also, the presence of well-equipped healthcare institutions and the ready acceptance of novel approaches in medicine will lead to rapid growth and development of Nuclear Medicine Molecular Imaging Technology practices.
On the basis of market status, presently, the global nuclear medicine market is rather fragmented, with nearly 70 companies selling radiopharmaceuticals on a regular basis. Three companies control almost half of the world market, while 56 firms share 14 percent of the market.
Global top manufacturers operating in Nuclear Medicine Molecular Imaging Technology market are Bayer; Sun Pharmaceutical Industries; Otsuka Pharmaceuticals, NuView Life Sciences; Norgine, Navidea, Ipsen, AAA and IHS Zevacor among others.
Nuclear Medicine Molecular Imaging Technology Report by Material, and Geography - Global Forecast to 2025 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).
The report firstly introduced the Nuclear Medicine Molecular Imaging Technology basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.